Description
Sytrax 1500 Injection is a broad-spectrum antibacterial combination of Ceftriaxone (a third-generation cephalosporin) and Sulbactam (a β-lactamase inhibitor). This synergistic formulation enhances antibacterial efficacy by overcoming resistance caused by β-lactamase–producing organisms.
Composition (Typical)
- Ceftriaxone Sodium IP – 1000 mg
- Sulbactam Sodium IP – 500 mg
- Total: 1500 mg
Mechanism of Action
- Ceftriaxone: Inhibits bacterial cell wall synthesis leading to cell lysis
- Sulbactam: Inhibits β-lactamase enzymes, protecting Ceftriaxone from degradation and extending its antibacterial spectrum
Indications
- Lower respiratory tract infections (pneumonia, bronchitis)
- Urinary tract infections (UTIs)
- Intra-abdominal infections
- Skin & soft tissue infections
- Bone & joint infections
- Septicemia
- Gynecological infections
Dosage & Administration
- Administer via Intramuscular (IM) or Intravenous (IV) route
- Reconstitute with appropriate diluent before use
- Dosage to be determined by the physician based on severity and patient profile
Key Benefits
- Dual-action formula for enhanced bacterial coverage
- Effective against β-lactamase–producing organisms
- Proven efficacy in moderate to severe infections
- Suitable for hospital and clinical use
Precautions
- Use cautiously in patients with penicillin/cephalosporin allergy
- Monitor renal and hepatic function during prolonged therapy
- Avoid unnecessary use to prevent antibiotic resistance
Storage
- Store in a cool, dry place below 25°C
- Protect from light
- Use immediately after reconstitution
Pack Details
- Vial containing 1500 mg dry powder for injection
